What’s the secret to aging well? University of Minnesota Medical School researchers have answered it- on a cellular level.
Aging starts in our cells, and those aging cells can hasten cellular senescence, leading to tissue dysfunction and related health impacts.
New research involving University of Minnesota Medical School faculty Paul D. Robbins and Laura J. Niedernhofer, recently published in Nature Medicine, shows there are types of small molecules called senolytics that can reverse the impact of aged, senescent cells.
“We’ve always thought of aging as a process, not a disease,” said Dr. Robbins, Associate Director of the newly founded Institute on the Biology of Aging and Metabolism (iBAM). “But what if we can influence the impacts of aging at a cellular level to promote healthy aging? That’s what senolytics seeks to achieve.”
The research determined whether introducing senescent cells to human and animal tissue would impact the cellular health of surrounding cells. Surprisingly, the transplant of a relatively small number of senescent cells caused persistent physical dysfunction as well as the spread of cellular senescence in previously healthy cells.
In addition, researchers found that a high fat diet, which causes a type of metabolic stress, or simply being old, enhances the physical dysfunction that comes from senescent cells.
“Previous research has shown that our immune system’s ability to eliminate or deal with senescent cells is based 30 percent on genetics and 70 percent on environment,” said Dr. Robbins, noting that what we eat and how often we exercise can affect senescence or aging of cells.
Conversely, the researchers determined that treatment with senolytic drugs, able to eliminate senescent cells, can reverse physical dysfunction and actually extend lifespan even when used in aged animal models.
“We saw greater activity, more endurance, and greater strength following use of senolytics,” said Dr. Robbins.
The paper notes that the results provide proof-of-concept evidence that improved health and lifespan in animals is possible by targeting senescent cells. The hope is that senolytics will prove effective in alleviating physical dysfunction and resulting loss of independence in older adult humans as well.
“This area of research is promising, not just to address the physical decline that comes with aging, but also to enhance the health of cancer survivors treated with radiation or chemotherapy – two treatments that can induce cell senescence,” said Laura Niedernhofer, Director of iBAM.
The Latest on: Senolytic drugs
via Google News
The Latest on: Senolytic drugs
- Could an existing heart drug help treat cancer?on October 22, 2019 at 12:18 am
Recently, however, researchers from the MRC London Institute of Medical Sciences in the United Kingdom may have identified an alternative senolytic — in the form of an existing heart drug known as ...
- Heart Drugs Re-purpose to Target Cancer Cellson October 21, 2019 at 12:17 pm
A new set of senolytic drugs has been discovered by scientists. The finding of the study is published in Nature Metabolism from the Cell Proliferation group at the MRC London Institute of Medical ...
- Identification and characterization of Cardiac Glycosides as senolytic compoundson October 21, 2019 at 8:15 am
These vulnerabilities can be exploited for therapeutic purposes as evidenced by the in vivo eradication of tumors xenografted in mice after treatment with the combination of a senogenic and a ...
- Repurposing heart drugs to target cancer cellson October 21, 2019 at 8:04 am
The fact that ouabain can eliminate different types of senescent cells emphasises its potential as a broad spectrum senolytic. Jesús Gil, Head of the Cell Proliferation group at the MRC LMS and senior ...
- Tech guru who plans to live to 200 years old spends £80MILLION on ‘immortality science’ – including robot avatars and anti-ageing drugson September 24, 2019 at 2:20 am
"We are investing in things like early diagnosis of cancer, artificial intelligence for drug development. "I'm meeting more than 100 companies a year. It's an exciting space." One of his backed ...
- Mayo Clinic trial shows drugs can rid body of old ‘senescent’ cellson September 18, 2019 at 7:15 am
This trial — involving participants who had diabetes-related kidney disease — is the second clinical study of senolytics to be published by Mayo, but is the first trial to show that senolytic drugs, ...
- Kidney disease: Senescent cell burden is reduced in humans by senolytic drugson September 18, 2019 at 5:14 am
In a small safety and feasibility clinical trial, researchers have demonstrated for the first time that senescent cells can be removed from the body using drugs termed 'senolytics.' The result was ...
- Mayo researchers demonstrate senescent cell burden is reduced in humans by senolytic drugson September 18, 2019 at 4:04 am
This trial -- involving participants who had diabetes-related kidney disease -- is the second clinical study of senolytics to be published by Mayo, but is the first trial to show that senolytic drugs, ...
- Researchers demonstrate senescent cell burden is reduced in humans by senolytic drugson September 18, 2019 at 4:00 am
In a small safety and feasibility clinical trial, Mayo Clinic researchers have demonstrated for the first time that senescent cells can be removed from the body using drugs termed "senolytics". The ...
via Bing News